
Full Supreme Court Press
What A Day
00:00
The FDA's Response to the Supreme Court Decision on Miffa-Pristone
A manufacturer of the generic version of Miffa-Pristone has also filed a lawsuit. The FDA interpreted last week's ruling from the Fifth Circuit Court of Appeals to include the generic medication. Other pharmaceutical companies recognize that this case will have an impact on their ability and sound standing to approve medications.
Transcript
Play full episode